Skip to Main Navigation Skip to Main Content Skip to Footer
search play2 play3 facebook twitter linkedin2 cross instagram
ASCP
  • DASHBOARD
  • STORE
  • LOGOUT
  • STORE
  • LOGIN
Menu
  • Jobs
  • ASCP
  • User Auth Test Page
  • Meeting the Needs of a Rural Community During the COVID-19 Pandemic: The Ups and Downs of Starting a University Based Clinical Lab for COVID-19 Testing, From Idea to Final Completion

    Abstract Not Available
    Full Article
  • Feed the Safety Need

    Abstract Not Available
    Full Article
  • Public Health Officials Begin Recommending Face Mask Use As Respiratory Viruses Surge

    The Washington Post (12/7, Nirappil, Parker-Pope) reports that “with three highly contagious respiratory viruses” – RSV, influenza, and COVID-19 – “sickening adults and children around the country and holiday gatherings just weeks away, public health offi...
    Full Article
  • More Than 25% Of Patients Coinfected With Virologically-Suppressed HIV And Chronic HBV Experience HBV Replication Event After Two Years Of Tenofovir-Based ART, Study Finds

    Infectious Disease Advisor (12/7, Nye) reports, “More than 25% of patients coinfected with virologically-suppressed HIV and chronic hepatitis B virus (HBV) experienced an HBV replication event after 2 years of tenofovir-based antiretroviral therapy (ART),...
    Full Article
  • Patients With IBD Treated With Infliximab Who Are Vaccinated Against SARS-CoV-2 More Likely To Have Breakthrough Infection Than Patients Treated With Vedolizumab, Researchers Say

    HCPlive (12/7, Walter) reports, “Patients with inflammatory bowel disease (IBD) treated with infliximab who were vaccinated against SARS-CoV-2 were more likely to have a breakthrough infection than patients treated with vedolizumab, but the benefits of th...
    Full Article
  • COVID-19 Drug Nirmatrelvir/Ritonavir Expected To Hit Private Market In Mid-2023

    Kaiser Health News (12/7, Recht) reports that “nearly 6 million Americans have taken” nirmatrelvir/ritonavir (Paxlovid) “for free, courtesy of the federal government.” However, “the government plans to stop footing the bill within months, and millions of...
    Full Article
  • Few Infectious Disease Physicians In US Waivered To Prescribe Buprenorphine, Study Finds

    Healio (12/7, Stulpin) reports, “Few infectious disease physicians are waivered to prescribe buprenorphine, despite being ‘well-positioned’ to treat opioid use disorder, according to” a “cross-sectional study that merged data from several publicly availab...
    Full Article
  • FDA To Review Pfizer’s RSV Vaccine Candidate For Older Adults On Priority

    Reuters (12/7, Satija, Mandowara) reports Pfizer “said on Wednesday the U.S. Food and Drug Administration will review its respiratory syncytial virus (RSV) vaccine candidate on priority.” Pfizer “is seeking approval for use of the vaccine, RSVpreF, in adu...
    Full Article
  • Changes In Gene Expression Patterns In The Brain Tied To Natural Aging Also Observed In Brains Of Those With Severe COVID-19, Researchers Say

    Healio (12/6, Downey) reports, “Changes in gene expression patterns in the brain associated with natural aging also were observed in the brains of those with severe COVID-19, prompting researchers to emphasize the need for neurological follow-up in recove...
    Full Article
  • Boston To Establish 11 Wastewater Testing Sites To Monitor For Spikes In COVID-19

    The AP (12/6) reports, “Boston is planning to establish 11 wastewater testing sites across the city to help monitor for spikes in the COVID-19 virus.” Boston Public Health Commission Executive Director Bisola Ojikutu, MD, MPH, “said the city is partnering...
    Full Article
  • Cold Air Exposure Damages Immune Response Occurring In The Nose, May Explain Seasonal Variation In Respiratory Illnesses, Researchers Say

    CNN (12/6, LaMotte) reports that in a study published in The Journal of Allergy and Clinical Immunology, researchers “may have found the biological reason we get more respiratory illnesses in winter,” revealing that “the cold air itself damages the immune...
    Full Article
  • PCV13 May Have Averted 35,000 Hospitalized Pneumonia Cases Among Medicare Part A/B Recipients In Recent Years, Study Suggests

    MedPage Today (12/6, Hein) reports, “The 13-valent pneumococcal conjugate vaccine (PCV13; Prevnar 13) may have averted 35,000 hospitalized pneumonia cases among Medicare Part A/B recipients in recent years, a cohort study suggested.” From “2014 to 2017, t...
    Full Article
  • Certain Diabetes Medications Tied To Better COVID-19 Outcomes Than Others, Systematic Review Finds

    MedPage Today (12/6, Monaco) reports, “Certain diabetes medications were tied with better COVID-19 outcomes than others,” according to a 31-study systematic review and meta-analysis. The findings, published in JAMA Network Open, showed “people with diabet...
    Full Article
  • Pfizer, Clear Creek Bio Announce Collaboration To Develop New Class Of Oral Treatment Against COVID-19

    Reuters (12/6, Mandowara) reports Pfizer “and Clear Creek Bio Inc on Tuesday announced a collaboration to identify a potential drug candidate and develop a new class of oral treatment against COVID-19, as Pfizer seeks to expand its anti-infective pipeline...
    Full Article
  • Central Ohio Measles Outbreak Grows To More Than 50 Children

    CNN (12/6, Howard) reports, “A measles outbreak in central Ohio is growing, sickening more than 50 children, with many of them needing hospitalization, according to data updated Tuesday by Columbus Public Health.” Since the beginning “of the outbreak in N...
    Full Article
  • US To Delay Decision On Extending Patent Waivers For COVID-19 Treatments, Tests

    Reuters (12/6, Blenkinsop, Farge) reports that on Tuesday, the US “urged delaying a decision on whether to waive patent protection for COVID-19 treatments and tests, as demanded by many developing countries.” In June, World Trade Organization members agre...
    Full Article
  • Pfizer, BioNTech Ask FDA To Authorize Bivalent COVID-19 Vaccine For Children Under Age Five

    The AP (12/5, Neergaard) reports, “Pfizer is asking U.S. regulators to authorize its updated COVID-19 vaccine for children under age 5 – not as a booster but part of their initial shots.” The article adds, “Children ages 6 months through 4 years already a...
    Full Article
  • Valneva Reports Positive 12-Month Antibody Persistence Data For Chikungunya Vaccine Candidate

    Reuters (12/5, Hummel) reports, “Vaccines company Valneva on Monday reported positive 12-month antibody persistence data for its single-shot Chikungunya vaccine candidate.” The company “said in a statement it was currently on track to complete its submiss...
    Full Article
  • Use Of Ad26. ZEBOV As Booster Dose A Safe, Immunogenic Vaccine Regimen For Ebola Virus Disease In Children, Trial Shows

    Infectious Disease Advisor (12/5, Barowski, RN) reports, “The use of the adenovirus type 26 vector-based vaccine encoding the Ebola virus glycoprotein of the Mayinga variant (Ad26. ZEBOV) as a booster for children who previously received 2 doses of the Ad...
    Full Article
  • COVID-19 Vaccination During Pregnancy Tied To Increased Concentrations Of Maternal Antibodies, Study Finds

    Infectious Disease Advisor (12/5, Cimino) reports, “COVID-19 vaccination during pregnancy is associated with increased concentrations of maternal immunoglobulin (Ig) G, cord blood IgG, and higher transfer ratio; however, maternal IgG concentrations decrea...
    Full Article
  • «
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • »
Footer
Chicago (Headquarters)
33 West Monroe Street, Suite 1600, Chicago, IL 60603

Privacy Policy 

Terms of Use

Follow Us

Copyright ©2021  by American Society for Clinical Pathology. All Rights Reserved.

Chat With BOC

close
First Name *
Last Name *
Email *
Customer ID

Request a Call from Customer Relations

Close
Name *
Topic *
Phone Number *
Scheduled Date *
Scheduled Time *
Customer Id